Last reviewed · How we verify

Magnesium sulfate 12 hours — Competitive Intelligence Brief

Magnesium sulfate 12 hours (Magnesium sulfate 12 hours) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Anticonvulsant, electrolyte supplement. Area: Obstetrics, Neurology.

marketed Anticonvulsant, electrolyte supplement Neuromuscular junction (calcium channel antagonist at motor endplate) Obstetrics, Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Magnesium sulfate 12 hours (Magnesium sulfate 12 hours) — Instituto Materno Infantil Prof. Fernando Figueira. Magnesium sulfate acts as a central nervous system depressant and anticonvulsant by blocking N-methyl-D-aspartate (NMDA) receptors and reducing neuromuscular transmission.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Magnesium sulfate 12 hours TARGET Magnesium sulfate 12 hours Instituto Materno Infantil Prof. Fernando Figueira marketed Anticonvulsant, electrolyte supplement Neuromuscular junction (calcium channel antagonist at motor endplate)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Anticonvulsant, electrolyte supplement class)

  1. Instituto Materno Infantil Prof. Fernando Figueira · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Magnesium sulfate 12 hours — Competitive Intelligence Brief. https://druglandscape.com/ci/magnesium-sulfate-12-hours. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: